|
PAICS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.678300E-03 |
| Normal-vs-Stage3 |
8.94839757847876E-14 |
| Normal-vs-Stage4 |
4.44089209850063E-16 |
| Stage1-vs-Stage2 |
1.342050E-02 |
| Stage1-vs-Stage3 |
1.148170E-01 |
| Stage1-vs-Stage4 |
9.276600E-03 |
| Stage2-vs-Stage3 |
9.237900E-04 |
| Stage2-vs-Stage4 |
2.848900E-04 |
| Stage3-vs-Stage4 |
4.664400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
8.1770999971198E-08 |
| Normal-vs-Asian |
1.82409642945913E-12 |
| Caucasian-vs-AfricanAmerican |
8.496200E-01 |
| Caucasian-vs-Asian |
5.578200E-01 |
| AfricanAmerican-vs-Asian |
8.979800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.78665979180914E-14 |
| Normal-vs-Female |
1.63002944475465E-12 |
| Male-vs-Female |
2.146600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65722990885797E-12 |
| Normal-vs-Age(41-60Yrs) |
3.10862446895044E-15 |
| Normal-vs-Age(61-80Yrs) |
3.05329983518732E-10 |
| Normal-vs-Age(81-100Yrs) |
6.344100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.304200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.450400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.311000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.404600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.161800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.393200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.718800E-01 |
| Classical-VS-Follicular |
4.243100E-03 |
| Classical-VS-Other |
5.853000E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.881800E-03 |
| Tall-VS-Other |
9.849400E-01 |
| Tall-VS-Normal |
3.43659989354705E-10 |
| Follicular-VS-Other |
1.992230E-01 |
| Follicular-VS-Normal |
1.87681999999079E-05 |
| Other-VS-Normal |
2.404300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.67319557787505E-11 |
| Normal-vs-N1 |
1.22124532708767E-15 |
| N0-vs-N1 |
7.841000E-04 |
|
|
